Geetanjali Kapoor

Director, OHT India

Geetanjali Kapoor is the Director of OHT, India, and is based in Bangalore, India.

Dr. Kapoor heads India operations at the One Health Trust. She develops partnerships for the control of infectious diseases and mitigation of antimicrobial resistance. She is supporting the establishment of the world’s first One Health Demographic and Health Surveillance System, a platform for implementing longitudinal studies across communicable and non-communicable diseases. Dr. Kapoor served as antimicrobial resistance (AMR) focal point for the implementation of the Fleming Fund Regional Grant in Africa (Mapping Antimicrobial Resistance and Antimicrobial Use Partnership), developed partnerships in the Indian subcontinent for the expansion of OHT’s AMR database ResistanceMap (ResMap), and co-authored “State of the World’s Antibiotics Report 2021,” a compilation of global AMR data and correlates. She contributed to the development of the African antibiotic treatment guidelines for common bacterial infections and syndromes. She is also a member of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) scientific advisory board and WHO Advisory Group on the bacterial priority pathogen list.

Previously, Dr. Kapoor worked as a clinical microbiologist in India and Kuwait, and as a consultant with the India office of the World Health Organization. She has contributed to India’s national infection prevention guidelines and state action plans for AMR control.

Dr. Kapoor is a clinical microbiologist by training at Jawaharlal Nehru Medical College, Aligarh, India, and holds a Master’s in Public Health from Johns Hopkins University. She completed her senior residency at the All India Institute of Medical Sciences in New Delhi, India, and did her fellowship in general infectious diseases at Christian Medical College, Vellore, India.

Her research interests are antimicrobial resistance surveillance, infectious disease and outbreak management, health systems strengthening, and health policy formulation.


Contact Geetanjali: [email protected]